Pricing

September 27, 2020

Even advocates of U.S. drug pricing reform recognize that President Trump's revised initiative to reduce the price of prescription drugs is unlikely to save money for consumers or the government.

September 13, 2020

President Trump has taken on the pharma industry in a surprise move making significant cuts in reimbursement for drugs covered by Medicare.

September 11, 2020

Tasked with setting up framework for essential medicine program.

August 24, 2020

COVID-19 has only magnified well known flaws of our healthcare system. An extension of Medicare is the affordable solution, writes Bruno Delagneau, and pharma needs to start planning for this to minimize its impact on US revenues.

August 18, 2020

A look into the complex battle between pharmaceutical manufacturers and payers for balance between medication access and budget management.

August 11, 2020

Should therapies and vaccines be cheap or free in a pandemic and would that really dry up innovation?

August 09, 2020

White House initiative to encourage U.S. production of essential medicines calls on FDA to set program parameters for implement main aspects.

July 21, 2020

Should therapies and vaccines be cheap or free in a pandemic and would that really dry up innovation?

April 18, 2020

Bill Barr outlines the systematic application of three criteria to guide discounting decisions.

March 19, 2020

The rapid pace of new pharmaceutical approvals raises questions of whether ICER can keep up and maintain the quality and rigor demanded by healthcare audiences, writes Jeremy Schafer.